J Clin Oncol May 2017 PMID 28447913

Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer.

Stacy Loeb, Yasin Folkvaljon, Jan-Erik Damber, Joseph Alukal, Mats Lambe, Pär Stattin

Download social card

Mentions

Peak: 4 in Feb 2025

across 5 sources since Aug 2024

Extended reach

449,796

potential audience

Total likes

Video views

911

Mentions per month

Aug 2024 – Mar 2025

Where it's discussed

News6 articles
Blogs4 articles
X / Twitter3 posts
YouTube3 videos
Facebook2 posts

AI synopsis

What people are saying

The discussions reflect a cautious curiosity, with mentions of references and questions about the link between testosterone levels and cancer, using neutral and investigative language. The tone indicates interest in the potential implications of the study but does not delve into complex debates or critique the methodology extensively.

AgreementModerate agreement

Most discussions seem to agree with the article's findings, emphasizing the potential protective aspect of TRT against aggressive prostate cancer.

InterestModerate interest

The posts show moderate interest, mainly focusing on the relationship between testosterone levels and cancer risk, without deep technical analysis.

EngagementNeutral engagement

While some comments mention references and raise questions, overall engagement appears surface-level, lacking detailed critique or extensive discussion.

ImpactModerate impact

The discussions hint at clinical relevance, particularly regarding treatment approaches, but do not demonstrate widespread or profound influence.

Abstract in brief

The study examined the link between testosterone replacement therapy (TRT) and prostate cancer risk using data from Sweden, including over 38,000 cases and nearly 200,000 controls, and found no overall increased risk of prostate cancer from TRT.
Patients on TRT were more likely to have favorably graded prostate cancers and less likely to have aggressive forms, with the favorable cases rising early after treatment begins, possibly due to detection bias.
The finding that TRT is associated with a lower risk of aggressive prostate cancer is new and suggests that further research is needed to understand this relationship better, especially considering potential biases in diagnosis.]

Read the full abstract